Last update:

Gastroenterology news

Gut microbiome could help identify people at risk of dementia

In what is thought to be the first study of its kind, researchers from Cardiff University and Imperial College London examined both gut bacteria and chemicals. Their findings could support earlier diagnosis and help spot ...

Antibiotic use from childhood linked to higher odds of IBS in young adulthood

Antibiotic use from childhood through early adulthood was associated with higher odds of irritable bowel syndrome (IBS) at age 24, with the odds increasing as the number of antibiotic prescriptions rose, according to a new ...

Imaging-based modalities compared for identifying at-risk MASH

FibroScan-aspartate aminotransferase (FAST) demonstrated the highest sensitivity for ruling out at-risk metabolic dysfunction-associated steatohepatitis (MASH), according to a study published in the October issue of the American ...

Kombucha may support mood and gut health

Researchers from the University of Minnesota found that drinking kombucha was associated with reduced anxiety and depressive-like behaviors in mice.

Untangling the link between depression and gut disease

Depression and gastrointestinal disorders frequently occur together. UC Irvine experts wondered if knowing which tends to be diagnosed first could shed light on the well-established but not yet fully understood gut-brain ...

How a diet free from animal proteins challenges the liver

Although a plant-based diet is recommended, notably for its environmental benefits, the health consequences of such a diet—in which protein intake is exclusively plant-based—are not yet fully understood. Scientists at the ...

Aspirin rarely used for colorectal cancer prevention

People with Lynch syndrome have a significantly increased risk of developing colorectal cancer and other types of cancer due to a hereditary predisposition. The CAPP2 study had already shown in this high-risk group that acetylsalicylic ...

An immune defect that may set Crohn's disease in motion

Crohn's disease, a condition characterized by widespread inflammation in the gut, may arise from a weakened immune response, according to new research from the University of Toronto's Temerty Faculty of Medicine.

New cellular clues to complications of scleroderma

A study published in JCI Insight and led by Northwestern Medicine scientists has uncovered new clues about why people with systemic sclerosis, also known as scleroderma, frequently develop debilitating esophageal complications.

New approach opens rare immune cells to genetic risk research

Much of how genetic risk leads to disease has remained hidden. In many cases, genetic variants linked to disease do not act on nearby genes along the chromosome. Instead, they influence genes located far away along the DNA ...

A new target in the gut for reducing Alzheimer's risk

A compound produced by bacteria in many people's digestive tracts increases the risk of developing Alzheimer's disease and speeds cognitive decline in dementia patients, making it a potential target for a treatment that could ...